Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(20 sites)
United States
Children's Hospital Los Angeles, Los Angeles, California Children's Hospital Orange County, Orange, California UCSF School of Medicine, San Francisco, California Colorado Children's Hospital, Denver, Colorado Children's Healthcare of Atlanta at Egleston, Atlanta, Georgia Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois Johns Hopkins / Sydney Kimmel Cancer Center, Baltimore, Maryland C.S. Mott University of Michigan, Ann Arbor, Michigan Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota Columbia University Medical Center, New York, New York Levine Children's Hospital, Charlotte, North Carolina Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio Nationwide Children's Hospital, Columbus, Ohio Oregon Health & Science University, Portland, Oregon Children's Hospital of Philadelphia, Philadelphia, Pennsylvania University of Texas, Southwestern, Dallas, Texas Cook Children's Medical Center, Fort Worth, Texas Baylor Texas Children's Hospital, Houston, Texas Primary Children's Hospital, Salt Lake City, Utah Children's Hospital of Wisconsin, Milwaukee, Wisconsin Last updated October 2023